Clinical Trials on Clostridium; Sepsis in Austria

Total 121 results

Medical University of Vienna

Unknown

Simvastatin in Patients With Septic Shock

Septic Shock

Austria
Biomedizinische Forschungs gmbH
Medical University of Vienna

Completed

rTSST-1 Variant Vaccine Phase 1 First-in-man Trail (rTSST-1)

Toxic Shock Syndrome | Vaccination; Sepsis

Austria
Melbourne Health
University of Melbourne; Monash Medical Centre; The Florey Institute of Neuroscience...

Recruiting

High-dose Intravenous Vitamin C in Patients With Septic Shock (HIGH-VIS)

Septic Shock | Sepsis, Severe

Australia
Medical University of Vienna

Completed

Evaluation of Intestinal Brush Border Enzyme Function in Critically Ill Patients

Critical Illness | Septic Shock | SIRS

Austria
Valneva Austria GmbH

Completed

An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84

Clostridium Difficile Infection

Austria, Hungary
Biomedizinische Forschungs gmbH
Medical University of Vienna

Completed

Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

Toxic Shock Syndrome

Austria
Medical University Innsbruck

Completed

Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis

Sepsis | Septic Shock | Cytokine Storm | Cytokine Release Syndrome | Catecholamine

Austria
AstraZeneca

Completed

A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock

Septic Shock | Severe Sepsis

Czech Republic, France, Spain, Finland, Canada, Australia, Belgium
Astellas Pharma Europe Ltd.
Cubist Pharmaceuticals LLC

Terminated

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

Clostridium Difficile

Spain, France, Germany, Greece, Denmark, Austria, Poland
Hannover Medical School

Not yet recruiting

Efficacy of add-on Plasma Exchange as an Adjunctive Strategy Against Septic Shock (EXCHANGE-2)

Septic Shock

Switzerland, Austria, Germany
University of Pittsburgh
National Institute of General Medical Sciences (NIGMS)

Completed

Protocolized Care for Early Septic Shock (ProCESS)

Sepsis | Septic Shock | Severe Sepsis

United States
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
The George Institute

Completed

Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS (FluDReSS)

Septic Shock | Critically Ill

Australia
Medical University of Graz

Completed

Investigation of Correlation Between Interstitial and Arterial Blood Glucose Concentrations in Septic Patients

Severe Sepsis

Austria
Centre Hospitalier Universitaire de Nīmes

Completed

Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis

Septic Shock | Peritonitis

France, Australia
RWTH Aachen University
Biotest

Recruiting

Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis (PEPPER Trial). (PEPPER)

Sepsis | Septic Shock | Peritonitis

Austria, Germany
Pfizer

Completed

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Clostridium Difficile Associated Disease

United States
The George Institute
National Health and Medical Research Council, Australia; Australian and New...

Completed

ADjunctive coRticosteroid trEatment iN criticAlly ilL Patients With Septic Shock (ADRENAL)

Septic Shock

Australia, Denmark, Saudi Arabia, New Zealand, United Kingdom
Medical University of Vienna

Completed

Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB Patients

Sepsis

Austria
Australian and New Zealand Intensive Care Research...

Recruiting

Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis (ARISE FLUIDS)

Shock, Septic

Australia
Pfizer

Completed

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Clostridium Difficile Associated Disease

United States
Medical University of Vienna

Completed

Pharmacokinetics of Micafungin During Continuous Venovenous Hemofiltration (Mica-HDF)

Candida Sepsis

Austria
Medical University of Vienna

Completed

The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation

Sepsis | Healthy Volunteers

Austria
The University of Queensland
Royal Brisbane and Women's Hospital

Unknown

Exercise in Critically Ill Patients With Sepsis

Sepsis Syndromes

Australia
Pfizer

Completed

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

Clostridium Difficile Associated Disease

United States
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Austin Health
Northern Health and Social Care Trust; Western Hospital, Australia

Unknown

Angiotensin in Septic Kidney Injury Trial (ASK-IT)

Sepsis | Septic Shock | Acute Renal Failure

Australia
Medical University of Vienna

Completed

Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy

Pregnancy Complications | Neonatal Sepsis | GBS | Vaginal Infection

Austria
Medical University of Vienna

Completed

Oxytocin Effects on Cytokines and Endocrine Parameters After LPS Induced Systemic Inflammatory Effects in Healthy Volunteers

Sepsis

Austria
Astellas Pharma Europe Ltd.
Merck Sharp & Dohme LLC

Completed

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population (EXTEND)

Clostridium Difficile

Greece, Spain, Russian Federation, Denmark, Austria, Belgium, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, United Kingdom
Medical University of Graz

Completed

Modulation of Gut Microbiota in Early Sepsis: A Pilot Study (MGM-sepsis)

Sepsis

Austria
Pfizer

Completed

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Clostridium Difficile Associated Disease

United States
Eli Lilly and Company

Completed

Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock

Sepsis

Italy, United Kingdom, United States, Germany, Spain, Belgium, France, Australia, Czech Republic, Netherlands, Canada, Mexico, New Zealand, Finland, Portugal, Brazil, India, Switzerland
Medical University of Vienna

Completed

Anti-Inflammatory Effect of Statins in the Human Endotoxin Model

Endotoxemia

Austria
Medical University of Vienna

Completed

Ethnic Differences in the Inflammatory Response in Systemic Inflammation

Endotoxemia

Austria
University of Vienna

Completed

Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function

Endotoxemia | Dietary Habits

Austria
University of Vienna

Completed

Cereals and Intestinal Function

Endotoxemia | Diet, Healthy

Austria
Bernd Jilma

Completed

Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide (LPS_DF)

Endotoxemia | Healthy Volunteers

Austria
University of Vienna

Recruiting

Different Dietary Patterns

Endotoxemia | Diet, Healthy

Austria
Medical University of Vienna

Completed

Vorapaxar in the Human Endotoxemia Model

Healthy Volunteers

Austria
Resistell AG

Recruiting

Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia (PHENOTECH-1)

Bacteremia Sepsis

Austria, Spain, Switzerland
Green Beat

Completed

Probiotic Sport Study

Inflammation | Endotoxemia | Oxidative Stress

Austria
Medical University Innsbruck
Austrian Society of Periodontology

Completed

The Impact of Material on Microbiota in Association With Tongue and Lip Piercing

Bacteremia

Austria
Austin Health

Completed

A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients (MERO001)

Sepsis

Australia
Hadassah Medical Organization
European Society of Intensive Care Medicine; International Sepsis Forum; The...

Completed

Corticosteroid Therapy of Septic Shock - Corticus (Corticus)

Shock, Septic

United Kingdom, Germany, Austria, Belgium, France, Israel, Italy, Netherlands, Portugal
Barmherzige Brüder Linz

Completed

Possible Links Between Inflammation and Lipid Metabolism

Sepsis | Inflammation | Lipid Metabolism Disorder | LPS

Austria
Pfizer

Completed

Clostridium Difficile Vaccine Efficacy Trial (Clover)

Clostridium Difficile Infection

United States, Spain, Belgium, Taiwan, Japan, Portugal, Colombia, Korea, Republic of, Poland, Australia, Germany, Canada, Argentina, Bulgaria, Chile, Czechia, Finland, France, Hungary, Peru, Slovakia, Sweden, United Kingdom
Medical University of Graz

Completed

Clinical Evaluation of Novel Biomarkers in Patients With Septicemia (NOBIS)

Sepsis | Fungemia | Bacteremia

Austria
Medical University of Graz

Completed

Anticipative Diagnosis of Central Venous Catheter Related Bloodstream Infections

Bloodstream Infection Due to Central Venous Catheter

Austria
Australian and New Zealand Intensive Care Research...
Melbourne Health; The Alfred; Barwon Health; Wellington Hospital; Monash Health; Austin... and other collaborators

Completed

The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial (VITAMINS)

Sepsis | Shock, Septic | Critically Ill | Vasoplegic Syndrome

Australia, New Zealand, Brazil

Clinical Trials on Clostridium; Sepsis in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations